News

Legacy Pharmaceutical Packaging will recall one more lot of the heart and blood pressure drug losartan sent to Kroger Co. pharmacies because the drug contained a possible carcinogen. Legacy ...
Drug companies recalled hundreds of lots of the commonly-prescribed blood pressure and heart medications valsartan, losartan and irbesartan — alone or combined with other drugs — after testing ...
Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient.
One lot of Losartan tablets, used to treat high blood pressure, has been recalled by Sandoz because it includes “a trace amount” of N-nitrosodiethylamine, commonly referred to as NDEA.
Losartan Potassium Hydrochlorothiazide, 100mg/12.5mg, 90-count, lot Nos. BX35C020 and BX35C049 Losartan Potassium Hydrochlorothiazide, 100mg/12.5mg, 1000-count, lot Nos. BX35C022 and BX35C023 ...
LOSARTAN POTASSIUM and HYDROCHOLOROTHIAZIDE TABLETS, USP 100 mg/12.5 mg, 1000-count bottles, NDC number 13668-117-10, Lot BX35C023, expiration date 5/2019.
Also, in the Candesartan Versus Losartan Efficacy Comparison Study (CANDLE), candesartan cilexetil 16 mg, dose-titrated if necessary to 32 mg once daily (n=160), reduced trough DBP more ...
In the losartan group, five (6%) of 86 patients with diabetes and atrial fibrillation died of sudden cardiac death during the trial, compared with nine (2%) of 500 patients without atrial ...
Losartan is available in the form of tablet to be taken once or twice a day. You may take losartan either with food or on an empty stomach. For adults 50 mg per day is a recommended dose.
New findings about why losartan is effective in treating Marfan syndrome may reshape our thinking about patient management Key mechanism to control Marfan-associated aortic root widening may be ...
Thanks for this very nice website. I (47 year-old male) had a mild cardiac infarct in February 2005 and since on losartan (Cozaar) medication. I have a strong subjective feeling that losartan ...
More information: Michael A. Puskarich et al, A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19, EClinicalMedicine (2021).DOI: 10.1016/j.eclinm ...